Monitoring Alzheimer’s Progression by Detecting Pathological Variants in ß-amyloid Protein


Alzheimer’s is a neurogenerative disease that affects tens of millions of people worldwide and carries no clear genetic marker. A hallmark of Alzheimer’s is the accumulation of mutated beta-amyloid proteins, creating plaques around neurons that disrupt normal cell function in the brain. Quantum-Si’s next-generation protein sequencing™ technology can sequence and identify key ß-amyloid variants that are indicative of early-onset Alzheimer’s, which enables understanding of the underlying disease’s pathway to further optimize treatment responsiveness and identify targets with therapeutic potential.